SCUBI Trial - Phase 1 Safety trial of sibling-matched UCB for cerebral palsy

Chief Investigators: Fahey, Novak, Colditz. Cell Care and CPA (2015-2019) $900k.

Aims: Determine the safety and preliminary efficacy of sibling-matched UCB infused into children with CP. Determine the feasibility and acceptability and duration of effects.

Mechanism: Anti-inflammatory and trophic.

New Knowledge: Establishing safety, feasibility and preliminary efficacy of sibling-matched UCB.

Project members

Associate Professor Michael Fahey

Director of Neurogenetics, Monash Paediatrics
Monash University
Head of Child Neurology
Monash Children’s Hospital

Professor Iona Novak

Head of Research, Cerebral Palsy Alliance Research Institute
School of Medicine, The University of Sydney

Professor Paul Colditz

Director of the Perinatal Research Centre
The University of Queensland Centre for Clinical Research